Our Mission
The Cardiac Safety Research Consortium advances scientific knowledge on cardiac safety for new and existing medical products by building a collaborative environment based upon the principles of the FDA Critical Path Initiative as well as other public health priorities.

News + Events
Cardio-Oncology Meeting
Cardiovascular Safety In Oncology Trials: Providing Clarity for a New Era of Cancer Therapeutics
On December 1, FDA and EMA Oncology Division representatives, leading oncology and cardiology researchers, and industry experts met for a panel discussion focused on improving outcomes of oncology clinical trials by incorporating measures of CV risk into their design.
